An Anti‐GD2 Monoclonal Antibody Enhances Apoptotic Effects of Anti‐cancer Drugs against Small Cell Lung Cancer Cells via JNK (c‐Jun Terminal Kinase) Activation
Shoko Yoshida(Nagoya City University), Koichi Furukawa(Chubu University)
Cited by 62
Related Papers
Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis
|Nature Communications|2016|172
Enhancement of malignant properties of human glioma cells by ganglioside GD3/GD2
|International Journal of Oncology|2018|61
Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells
|Journal of Biological Chemistry|2016|38
Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
|Molecules|2020|35